Brilliant green phosphomolybdate pigment
Formula : C27-H33-N2.1/3Mo12-O40-P
CAS :
68334-64-5
Brilliant green phosphotungstate pigment
Formula : C27-H33-N2.1/3O40-P-W12
CAS :
68444-39-3
Brilliant lake red R
Formula : C17-H12-N2-O3
CAS :
27757-79-5
Brilliant sulfaflavine
Formula : C19-H14-N2-O5-S.Na
CAS :
2391-30-2
C.I. 56205
C.I. Acid Yellow 7
Acid Yellow 7
Brilliant acid flavine 10J
Brilliant Acid Yellow 8G
Brilliant Sulfa Flavine
Brilliant sulfaflavine
Brilliant Sulfo Flavin
Brilliant Sulfo Flavin FFA
Brilliant Sulfo Flavine
Brilliant Sulfo Flavine FF
Brilliant Sulfo Flavine FFA
Brilliant sulfoflavin
Brilliant Sulfoflavin FF
Brilliant Sulfoflavin FFA
Brilliant sulfoflavine FF
Brilliant sulphaflavine
Brilliant Sulpho Flavine
Brilliant Sulpho Flavine FF
Brilliant Sulpho Flavine FFA
EINECS 219-238-3
Fenazo Yellow XX
Kayaku acid brilliant flavine FF
Lissamine flavine FF
Lissamine Flavine FFS
NSC 322919
Solar Pure Yellow 8G
Sulfaflavine
Brilliant Yellow 6G
Formula : C34-H32-N6-O10-S2.2Na
CAS :
2429-76-7
C.I. 23900
C.I. Acid Yellow 44| disodium salt
Amacid Milling Yellow 5G
Azo Milling Yellow 3G
Belacid Milling Yellow 5G
Benzyl Yellow 8G
Brilliant Milling Yellow 8G
Brilliant Yellow 6G
Coomassie Yellow 7G
Diacid Milling Yellow H 5G
EINECS 219-386-9
Fenafor Yellow F 5G
Folan Yellow 7G
Milling Fast Yellow 5G
Milling Yellow H 5G
Milling Yellow 6G
Milling Yellow 7JL
Milling Yellow H 5GA-CF
Milling Yellow NGS
Milling Yellow NGS 1828
Optanol Yellow 5G
Peeracid Milling Yellow 6G
Sumitomo Milling Yellow H 5G
Tetracid Milling Yellow H 5G
Vondamol Fast Yellow H 5G
Xylene Milling Yellow 6G
Zoleien Folanowa 7G
Brilliantphosphine-imino
Formula : C18-H21-N3.N-O3
CAS :
66922-73-4
Brimonidine
Formula : C11-H10-Br-N5
CAS :
59803-98-4
Related to clonidine.
Brimonidine mixture with brinzolamide
Formula : C12-H21-N3-O5-S3.C11-H10-Br-N5
Drugs@FDA Label: SIMBRINZA (TM) (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.